News
High suPAR is related to accelerated aging, study in the Journals of Gerontology shows
"Association Between Elevated suPAR, a New Biomarker of Inflammation, and Accelerated Aging", published in the Journals of Gerontology To understand and measure the association between chronic inflammation, aging, and age-related diseases, broadly applicable standard biomarkers of systemic chronic inflammation [...]
Clinical Implementation of suPARnostic® TurbiLatex in routine use at The Arrixaca University Hospital in Spain
suPARnostic® TurbiLatex will now be available for clinical decision making in the Emergency Department of Hospital Clínico Universitario Virgen de la Arrixaca, located in the Murcia region in Spain. The hospital has started to use [...]
Is suPAR the strongest marker for COVID-19 risk identification?
By: Jesper Eugen-Olsen, PhD, Copenhagen University Hospital Hvidovre, Denmark The corona virus SARS-CoV-2 pandemic puts tremendous pressure on hospital resources and capacity. Clinical markers of progression are urgently needed in order to quickly discharge patients, who will not [...]
Region Zealand: we are there for you
By: Thomas Neil Skov, ViroGates Region Zealand (RZ) is one of five regions in Denmark.